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SUMMARY
We determined cytokines (e.g. interleukin-8, 10, 12 and TNF-α) expression by peripheral blood mononuclear cells
(PBMCs) and in rectal mucosa in diarrhoea-predominant irritable bowel syndrome (D-IBS) with Blastocystis spp. Eighty
patients with D-IBS and Blastocystis spp. infection were classiﬁed as ‘cases’ and 80 with D-IBS without Blastocystis spp.
infection were classiﬁed as ‘control’. Cases were subdivided into D-IBS andBlastocystis sp. deﬁned type 1 (subtype-speciﬁc
primer SB83) and type 3 (SB227). Stool microscopy and culture were performed. Rectal biopsies were obtained for
histology and cytokines by real-time PCR for mRNA expression of cytokines. PBMCs IL-8 was similar in diﬀerent groups
but in type 1, IL-8mRNA was increased compared with type 3 (P = 0·001) and control (P= 0·001). In type 1, IL-10 by
PBMCs had a low mean value (14·5±1·6) compared with (16·7±1·5) type 3 and (16±2·3) in controls (P<0·001 and
P<0·001, respectively). In Blastocystis sp. type 1, low IL-10 was associated with lymphocyte and plasma cell inﬁltration
(P= 0·015 and P= 0·002, respectively). InBlastocystis sp. type 1 and type 3, IL-12 was associated with goblet cell depletion
23 (85%) (P<0·001) and 8 (29%) (P= 0·037), respectively. In Blastocystis sp. type 1, low IL-10 was associated with a
proinﬂammatory response characterized by IL-8.
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INTRODUCTION
Blastocystis spp. is a protozoan parasite commonly
found in the human gastrointestinal tract. The
symptoms attributed to infection with Blastocystis
spp. include diarrhoea, abdominal pain or dis-
comfort, etc. Blastocystis spp. from humans and
animals exhibit similar morphological features.
Extensive genetic variability has been reported in
Blastocystis spp. of both human and animal origin.
A number of molecular techniques used to study
the genetic diversity of Blastocystis spp. include
PCR-restriction fragment length polymorphism
(RFLP) (Abe et al. 2003a,b, c), PCR followed by
dideoxy sequencing (Abe, 2004; Yoshikawa et al.
2004; Stensvold et al. 2006), and PCR with subtype-
speciﬁc (sequence-tagged site [STS]) primers (Abe
et al. 2003a,b, c; Khan and Alkhalife, 2005; Yakoob
et al. 2010).
Oral inoculation with 1×105 cysts of Blastocystis
sp. strain RN94-9 in rats resulted in chronic infection
in the caecum for 4 weeks after infection (Iguchi et al.
2009). Histological examination revealed only a slight
increase in goblet cells in the caecal mucosa 1–3 weeks
postinfection but no inﬂammatory cell inﬁltration
nor mucosal sloughing. Signiﬁcant upregulation of
the expression of interferon-γ, IL-12 and TNF-α,
but not IL-6 or granulocyte–macrophage colony
stimulating factor (GM-CSF) was demonstrated in
the caecal mucosa at 2 weeks post-infection. The
induction of local host responses, including mild
goblet cell hyperplasia, and signiﬁcant upregulation
of type-1 and proinﬂammatory cytokines, suggests
that Blastocystis sp. strain RN94-9 is a weakly
pathogenic organism that could elicit proinﬂamma-
tory as well as protective responses in local tissues
(Iguchi et al. 2009). The cysteine proteases of
Blastocystis rattiWR1, a zoonotic isolate, can activate
IL-8 gene expression in human colonic epithelial
cells. The molecular mechanism by which
Blastocystis activates IL-8 gene expression in
human colonic epithelial T84 cells and the pro-
duction of IL-8 is dependent on NF-κB activation
(Puthia et al. 2008). Previously, an experimental in
vitro study demonstrated Blastocystis spp. is able to
trigger inﬂammatory cytokine response in colonic
epithelial cells (Long et al. 2001). After 24 h
incubation of Blastocystis spp. with the cell lines
HT-29 and T-84, B. hominis cells were not able to
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cause cytopathic eﬀects, but signiﬁcantly increased
the release of IL-8 and GM-CSF. However, after the
ﬁrst 6 h of co-incubation, the production of IL-8 was
not increased in HT-29 cells and even reduced when
Escherichia coli (bacteria or lipopolysaccharide) were
present during co-incubation. Similar eﬀects were
observed using supernatants of Blastocystis spp.
culture. These data indicate that Blastocystis spp.
induces as well as modulates the immune response in
intestinal epithelial cells (Long et al. 2001).
Irritable bowel syndrome (IBS) is common and
has a signiﬁcant medical and socioeconomic impact.
It is considered to be a biopsychosocial disorder
resulting from an interaction among many factors
that included diet, gut microﬂora, visceral hyper-
algesia, genetic and environmental factors, infection,
inﬂammation, gut motility and psychological
factors (Drossman et al. 2002). IBS is associated
with abdominal pain or discomfort and an alteration
in bowel habits (Drossman et al. 2002). There has
been a suggestion that some patients with IBS
may harbour bacterial overgrowth leading to low-
grade inﬂammation (O’Leary and Quigley, 2003) and
immune activation (O’Sullivan et al. 2000; Chadwick
et al. 2002), and their symptoms may be ameliorated
by its eradication (Pimentel et al. 2000). Imbalances
in pro- and anti-inﬂammatory cytokine production
may promote ongoing low-grade inﬂammation after
an acute gastroenteritis, and subsequently lead to
IBS (van der Veek et al. 2005). Thus abnormal
neuroimmune interactions may contribute to the
altered gastrointestinal physiology and hypersensi-
tivity that underlies IBS (Barbara et al. 2002).
Previously, we demonstrated that stool culture for
Blastocystis spp. was positive in 46% of the patients
with D-IBS (Yakoob et al. 2004). In the present
study, we determined the cytokine proﬁle in patients
with D-IBS and in those with concomitant
Blastocystis sp. type 1 and 3 infection. We evaluated
cytokine production in vitro from PBMC and
determined tissue cytokine levels of IL-8, IL-10,
IL-12 andTNF-α. IL-12 is amarker of Th1 response
and IL-10 of T regulatory response. The outcome of
an immune response depends on the balance between
pro- and anti-inﬂammatory responses. We aimed
for a comprehensive overview of cytokine proﬁles
including the anti-inﬂammatory cytokine IL-10.
MATERIALS AND METHODS
Study population
This prospective study was conducted at the Aga
Khan University in Karachi, Pakistan. One hundred
and seventy patients with symptoms suggestive of
D-IBS, according to the Rome III criteria, who
attended the gastroenterology clinic from December
2009 to December 2011, were enrolled. Rome III
criteria deﬁne IBS as recurrent abdominal pain or
discomfort at least 3 days per month in the last
3 months that started at least 6 months before
diagnosis, cannot be explained by a structural or
biochemical abnormality, and is associated with at
least two of the following: improvement with
defecation, onset associated with a change in fre-
quency of stool, and onset associated with a change
in form (appearance) of stool (Drossman and
Dumitrascu, 2006). Other symptoms that support
the diagnosis but are not part of the criteria include
abnormal stool frequency (43 bowel movements per
week or >3 bowel movements per day), abnormal
stool form (lumpy/hard or loose/watery), defecation
straining, urgency, or feeling of incomplete bowel
movement, passing mucus and bloating. Four poss-
ible IBS subtypes include IBS with constipation
(C-IBS), IBS with diarrhoea (D-IBS), mixed IBS
(M-IBS) and un-subtyped IBS depending on the
predominant stool pattern (Drossman and
Dumitrascu, 2006). Of these ten patients were
excluded; three had coinfection of Giardia lamblia
and one Entameba coli with Blastocystis spp. while
there were 2 each with Blastocystis sp. types 2 and
4 and 1 each with Blastocystis sp. types 5 and 6,
respectively. Forty (25%) were infected with
Blastocystis sp. type 1 and 40 (25%) with
Blastocystis sp. type 3, respectively (Table 2).
Eighty patients with D-IBS and Blastocystis spp.
infection were deﬁned as ‘cases’ and 80 D-IBS
patients without Blastocystis spp. infection were
‘control’ (Table 1). Cases were subdivided into
patients with D-IBS and Blastocystis spp. infection
type 1 or type 3. Standardized subtype-speciﬁc
(STS) primers for Blastocystis sp. subtype 1 (SB83)
and subtype 3 (SB227) deﬁned Blastocystis sp. type 1
and 3. The study was approved by the Ethics
Committee of the Aga Khan University and written
informed consent was obtained from all patients.
After enrolment of eligible patients in the study, a
detailed history and physical examination was carried
out. Colonoscopy of the patient was performed to
rule out any organic disease and four rectal biopsies
were taken, two each for histopathology and cytokine
levels. Blood samples were obtained for cytokines
analysis. Three stool samples collected from each
patient on alternate days were examined by mi-
croscopy and cultured for Blastocystis spp. Coeliac
disease, small bowel bacterial overgrowth and lactose
intolerance were excluded by measuring tissue
transglutaminase antibodies (IgA and IgG) and
lactose intolerance by hydrogen breath test, respect-
ively. The inclusion criteria were adults from 18 to 61
years of age with D-IBS, satisfying ROME III
criteria (Drossman and Dumitrascu, 2006).
Exclusion criteria were pregnant and lactating
females, inﬂammatory bowel disease and other
systemic disease, patients on laxatives or anti-
diarrhoeal drugs that could inﬂuence the motility of
gut, patients on antibiotics that could alter the
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Table 1. Comparison of characteristics of controls with and without B. hominis infection
Blastocystis hominis
positive, n= 80
Blastocystis hominis
negative, n= 80 P value
Age (years)
435 years 33 (41) 32 (40) 0·872
536 years 47 (59) 48 (60)
Sex
Male 60 (75) 58 (72) 0·719
Female 20 (25) 22 (28)
Symptoms
Abdominal pain
Yes 68 (85) 65 (81) 0·527
No 12 (15) 15 (19)
Bloating
Yes 55 (69) 53 (66) 0·736
No 25 (31) 27 (34)
Stool frequency
44 per day 4 (5) 8 (10) 0·369
55 or more 76 (95) 72 (90)
Stool microscopy
Positive 55 (69) 0 (0) <0·001
Negative 25 (31) 80 (100)
Stool culture
Positive 80 (100) 0 (0) <0·001
Negative 0 (0) 80 (100)
Histology
Nonspeciﬁc colitis 58 (72) 53 (66) 0·391
Normal 22 (28) 27 (34)
Neutrophil
Absent 50 (63) 38 (47) 0·057
Mild 30 (37) 42 (53)
Eosinophil
Absent 37 (46) 47 (59) 0·113
Mild 43 (54) 33 (41)
Lymphocyte
Mild 62 (77) 64 (80) 0·699
Moderate 18 (23) 16 (20)
Plasma cells
Mild 62 (77) 58 (72) 0·465
Moderate 18 (23) 22 (28)
Goblet cell depletion
Absent 43 (54) 38 (47) 0·429
Mild 37 (46) 42 (53)
Intraepithelial lymphocyte
Absent 55 (69) 60 (75) 0·379
Mild 25 (31) 20 (25)
PBMC cytokines
IL-8
<12·4 pgmL−1 45 (56) 31 (39) 0·027
512·4 pgmL−1 35 (44) 49 (61)
IL-10
<15·8 pgmL−1 48 (60) 37 (46) 0·081
515·8 pgmL−1 32 (40) 43 (54)
IL-12
<5·8 pgmL−1 55 (69) 62 (77) 0·212
55·8 pgmL−1 25 (31) 18 (23)
TNF-α
<9·3 pgmL−1 28 (35) 32 (40) 0·514
59·3 pgmL−1 52 (65) 48 (60)
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enteric ﬂora, patients with any ongoing infection,
not willing to participate and those with Blastocystis
spp. infection of more than one genotype. We chose
to study only D-IBS patients as they were more
frequently documented to be positive for Blastocystis
spp. in our patients previously as compared with
other IBS subtypes (Yakoob et al. 2004). The stool
samples from D-IBS patients were screened with the
seven kinds of STS primers 1, 2, 3, 4, 5, 6 and
7.However, we studied only genotypes ofBlastocystis
sp. type 1 and 3 which are the predominant types
of Blastocystis spp. identiﬁed among our D-IBS
patients (Yakoob et al. 2010).
Histology
Colonic biopsy specimens were obtained from
rectum at the recto-sigmoid junction and were ﬁxed
immediately in 10% formalin in sodium phosphate
buﬀer and sent to the Department of Pathology for
processing. Biopsies were embedded in paraﬃn, and
histological sections were stained with haematoxylin
and eosin for evaluation. Histological inﬂammation
was graded as 0–3 (0 – nil or without evidence of
histopathology, 1 – mild, 2 – moderate, 3 – severe)
according to the inﬁltration by neutrophils, eosino-
phils, lymphocytes, plasma cells and epithelial cell
damage e.g. goblet cell depletion, intraepithelial cell
lymphocytes (IEL). The pathologist was blinded to
cytokine data.
Microscopy of fecal smear
Fecal sample microscopy was done as described
before (Zaman and Khan, 1994). Brieﬂy, approxi-
mately 2mg of feces was thoroughly emulsiﬁed on a
glass slide in one drop of physiological saline and
covered with a cover slip. A similar preparation was
made on another slide using Lugol’s iodine. These
preparations were examined under both the low
power (×10) and high dry (×40) objectives. Three
fecal samples were examined on alternate days before
giving a negative diagnosis of infection with an
intestinal protozoan.
Table 2A. The sequence-tagged site (STS) primer used
Subtypes
STS
primer
sets
Product
size (bp)
Sequences of forward (F) and
reverse (R) primers (5′ to 3′)
GenBank
accession no.
1 SB83 351 F GAAGGACTCTCTGACGATGA AF166086
R GTCCAAATGAAAGGCAGC
2 SB155 650 F ATCAGCCTACAATCTCCTC AF166087
R ATCGCCACTTCTCCAAT
3 SB227 526 F TAGGATTTGGTGTTTGGAGA AF166088
R TTAGAAGTGAAGGAGATGGAAG
4 SB332 338 F GCATCCAGACTACTATCAACATT AF166091
R CCATTTTCAGACAACCACTTA
5 SB340 704 F TGTTCTTGTGTCTTCTCAGCTC AY048752
R TTCTTTCACACTCCCGTCAT
6 SB336 317 F GTGGGTAGAGGAAGGAAAACA AY048751
R AGAACAAGTCGATGAAGTGAGAT
7 SB337 487 F GTCTTTCCCTGTCTATTCTGCA AY048750
R AATTCGGTCTGCTTCTTCTG
Table 2B. Cytokines primer sequence
Serial no. Gene Sequence
1. IL-12 5′-CACTCCAGACCCAGGAATGTTC-3′ F
5′-TTGTCTGGCCTTCTGGAGCAT-3′ R
2. IL 10 5′- ACGGCGCTGTCATCGATT-3′ F
5′ GGCATTCTTCACCTGCTCCA-3′ R
3. IL-8 5′-ACTGCGCCAACACAGAAATT-3′ F
5′-TTCTCCACAACCCTCTGCAC-3′ R
4. TNF-α 5′-CCCTGGTATGAGCCCATCTATC-3′ F
5′-AAAGTAGACCTGCCCAGACTCG-3′ R
5. GAPDH 5′-GAAGGTGAAGGTCGGAGTC-3′ F
5′-GAAGATGGTGATGGGATTTC-3′ R
F=Forward primer; R =Reverse primer.
Tsukada et al. (2002).
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Culture of feces
Blastocystis spp. culture was done by inoculating
approximately 50mg of feces into Jones’ medium.
Blastocystis spp. culture was performed using Jones
medium without starch (Zaman and Khan, 1994).
The cultures were incubated at 37 °C and examined
after 2–3 days for one week to exclude slow-growing
parasites. The sediment was examined under both
the low power (×10) and high dry (×40) objectives.
The positive samples were subcultured for another
3 days using fresh media.
Extraction of genomic DNA
Genomic DNA of Blastocystis spp. was extracted
by using a Stool DNA Extraction kit (Qiagen)
according to the manufacturer’s protocol. Extracted
DNA was stored at −20 °C until PCR was carried
out for Blastocystis spp. genotyping.
Blastocystis spp. genotyping by PCRwith STS primers
Seven kinds of STS primers developed for typing
the Blastocystis spp. isolates were used as described
previously (Table 2A) (Yoshikawa et al. 1998,
2000, 2003; Abe et al. 2003a,b; Yan et al. 2006;
Li et al. 2007a,b). Seven standardized subtype-
speciﬁc STS primers were used, namely SB83
(351 bp) for subtype 1, SB340 (704 bp) for subtype
2, SB227 (526 bp) for subtype 3, SB337 (487 bp)
for subtype 4, SB336 (317 bp) for subtype 5,
SB332 (338 bp) for subtype 6, and SB155 (650 bp)
for subtype 7 according to a recent classiﬁcation
terminology (Stensvold et al. 2007). Typing of the
Blastocystis spp. isolates was conducted through PCR
ampliﬁcation on the basis of the presence or absence
of the products with parallel control. The PCR
conditions consisted of one cycle denaturing at 94 °C
for 3min, 30 cycles including annealing at 59 °C for
30 s, extending at 72 °C for 60 s, denaturing at 94 °C
for 30 s, and additional cycle with a 5-min chain
elongation at 72 °C (PCR System 9700, Perkin
Elmer, USA). The PCR products and molecular
markers were electrophoresed in 2% agarose gel with
Tris-acetate-EDTA electrophoresis buﬀer. The size
markers were 100-bp ladder (Promega, USA). The
PCR ampliﬁcation for each primer pair was repeated
at least thrice. Bands were visualized by the imaging
system (Gel Doc 2000, Gel Documentation System,
Bio-Rad, UK) after being stained with ethidium
bromide.
Isolation of peripheral blood mononuclear cells
Blood samples from patients with D-IBS (approxi-
mately 4mL) were collected in sterile ethylene
diaminetetra-acetate (EDTA) containing tubes.
Peripheral blood mononuclear cells were isolated
using Histopaque (Sigma-Aldrich, USA) according
to the density gradient centrifugation method
(Chomczynski and Sacchi, 1987). The collected
PBMCs were washed twice with Roswell Park
Memorial Institute (RPM 1640) culture medium
and resuspended in growth medium of RPMI
supplemented with 10% foetal bovine serum
(FBS), 100UmL−1 penicillin-streptomycin and
2·5 μgmL−1 of fungizone at 37 °C in a CO2 incubator
containing 5% CO2, 95% air and 100% humidity. The
supernatant was removed after 3 days and stored at
−70 °C until further testing.
Cytokine assays
Cell culture supernatants were harvested and ana-
lysed for cytokines by ELISA techniques with
commercially available kits. Human IL-8, 10, 12
and TNF-α kits were obtained fromBDOptEIA. All
cytokine assays were calibrated against the World
Health Organization international standards by the
kit manufacturer. The lower limits of detection
for the individual assays are as follows: IL-8,
0·8 pgmL−1; IL-10, 2 pgmL−1; IL-12, 4 pgmL−1
and TNF-α, 2 pgmL−1.
Biopsy cytokines using real-time quantitative
PCR with SYBR Green
TRIzol. Intestinal biopsy specimens obtained
for RNA extraction were collected in an Eppendorf
vial containing TRIzols Reagent (Invitrogen
Corporation, USA) and stored in a liquid nitrogen
container for transport to the laboratory and stored at
−70 °C until further use. Total RNA was extracted
from endoscopic biopsy samples of colonic mucosa
with TRIzol method described previously. Reverse
transcription of the extracted RNA was performed
using RNase H-deﬁcient reverse transcriptase
(Superscript II, Life Technologies) and oligo (dT)
primers (Life Technologies). Aliquots (2 μL) of
reverse transcription reaction mixture (20 μL) were
used for quantitation of IL-12, IL 10, IL-8 TNF-α
and GAPDH gene expression by real-time PCR
assays (Table 2B) (Tsukada et al. 2002). The SYBR
GreenQRTPCRwas used to quantify IL-12, IL-10,
IL-8, TNF-α and GAPDH gene expression (PE
Applied Biosystems, Foster City, CA). The PCR
reactions were performed using the SYBR Green
QRT PCR kit (PE Applied Biosystems) as described
previously (Heid et al. 1996). After activation for
10min at 95 °C, 40 cycles of 15 s at 95 °C and 1min
at 62 °C was carried out in model icycler (Biorad).
Real-time ﬂuorescence measurements was recorded
and the threshold cycle (Ct) value for each sample
calculated by the above sequence detector (Heid et al.
1996). For IL-12, TNF-α and GAPDH standard
curves of Ct values were obtained from real-time
961Blastocystis spp. associated cytokine immune responses
PCR of pMFGhTNF, pBSKIhIL-12 and PCRII
GAPDH (Reference plasmids). The relative fold
change in mRNA expression of the target gene was
calculated with 2−∆∆CT method using the software
GENEX. The 2−∆∆CT method presents the data as
fold change in mRNA expression of the target gene,
normalized to the mRNA expression of the house-
keeping gene. Glyceraldehyde-3-phosphate de-
hydrogenase was used as the housekeeping gene in
all the QRT-PCR experiment. Each biopsy sample
obtained from the same patient was tested in
duplicate, and the average of two Ct values was
used in this study.
Statistical methods
Results are expressed as mean±S.D. for continuous
normally distributed variables whereas median with
IQR (interquartile range) for non-normal variables
and number (percentage) for categorical data.
Diﬀerences in mean comparison of characteristics of
IBS patients with and without Blastocystis sp.
infection type-I and 3 with control group for
normally distributed variables were performed by
using the analysis of variance (ANOVA) and Tukey’s
HSD test was used formultiple comparison, however
for non-normal variables a non-parametric Kruskal–
Wallis test and Mann–Whitney test were used for
within-group comparison. Diﬀerences in proportion
were compared by Pearson Chi-square or Fisher
exact where appropriate. A P value of <0·05 was
considered as statistically signiﬁcant. All P values
were two sided. Statistical interpretation of data was
performed by using the computerized software
program SPSS version 19.
RESULTS
Ninety-ﬁve (59%) of the patients were over 35 years of
age. Abdominal pain, bloating and frequency of stool
were equally common in both groups (Table 1). Fecal
smear microscopy for Blastocystis spp. was positive
in 55 (69%) and Blastocystis spp. culture was positive
in 80 (50%) (Table 1).
Blastocystis spp. subtypes and histology
Non-speciﬁc colitis was present in 58 (72%) with
Blastocystis spp. infection and in 53 (66%) without
(P= 0·391) (Table 1). Of the 58 Blastocystis positive
D-IBS with non-speciﬁc colitis, Blastocystis sp.
subtype 1 was 30 (75%) compared with control of
53 (66%) (P = 0·328) and Blastocystis sp. subtype 3
was 28 (70%) compared with control of 53 (66%)
(P= 0·679). There was no signiﬁcant diﬀerence
in the distribution of neutrophils, eosinophils,
mononuclear cells or evidence of epithelial cell
damage in the colonic mucosal biopsies in the two
groups (Table 1).
Blastocystis spp. types and PBMC cytokines
Patients with D-IBS infected with Blastocystis
spp. demonstrated low PBMC production of IL-8 in
Fig. 1. Comparison of PBMC cytokines with Blastocystis sp. type 1 and 3 and control.
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Table 3. Comparison of characteristics of controls with B. hominis type genotype
B. hominisType 1,
n= 40
Control,
n= 80 P value
B. hominisType 3,
n= 40
Control,
n= 80 P value
Age (years)
435 years 18 (45) 32 (40) 0·600 15 (37) 32 (40) 0·791
536 years 22 (55) 48 (60) 25 (63) 48 (60)
Gender
Male 28 (70) 58 (73) 0·774 32 (80) 58 (72) 0·371
Female 12 (30) 22 (27) 8 (20) 22 (28)
Abdominal pain
Yes 28 (70) 65 (81) 0·164 35 (87) 65 (81) 0·386
No 12 (30) 15 (19) 5 (13) 15 (19)
Bloating
Yes 23 (57) 53 (66) 0·348 32 (80) 53 (66) 0·118
No 17 (43) 27 (34) 8 (20) 27 (34)
Stool frequency
4 4 per day 4 (10) 8 (9) 0·999 6 (15) 8 (10) 0·421
55 per day 36 (90) 72 (91) 34 (85) 72 (90)
Stool microscopy
Positive 30 (75) 0 (0) <0·001 25 (62) 0 (0) <0·001
Negative 10 (25) 80 (100) 15 (38) 80 (100)
Stool culture
Positive 40 (100) 0 (0) <0·001 40 (100) 0 (0) <0·001
Negative 0 (0) 80 (100) 0 (0) 80 (100)
Histology
Nonspeciﬁc colitis 30 (75) 53 (66) 0·328 28 (70) 53 (66) 0·679
Normal 10 (25) 27 (34) 12 (30) 27 (34)
Neutrophil
Absent 26 (65) 38 (47) 0·070 24 (60) 38 (47) 0·196
Mild 14 (35) 42 (53) 16 (40) 42 (53)
Eosinophil
Absent 17 (42) 47 (59) 0·093 20 (50) 47 (59) 0·363
Mild 23 (58) 33 (41) 20 (50) 33 (41)
Lymphocyte
Mild 25 (63) 64 (80) 0·039 28 (70) 64 (80) 0·222
Moderate 15 (37) 16 (20) 12 (30) 16 (20)
Plasma cells
Mild 30 (75) 58 (73) 0·770 32 (80) 58 (73) 0·371
Moderate 10 (25) 22 (27) 8 (20) 22 (27)
Goblet cell depletion
Absent 27 (67) 38 (47) 0·038 16 (40) 38 (48) 0·436
Mild 13 (33) 42 (53) 24 (60) 42 (52)
Intraepithelial
lymphocyte
Absent 23 (57) 60 (75) 0·050 32 (80) 60 (75) 0·542
Mild 17 (43) 20 (25) 8 (20) 20 (25)
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45 (56%) (P = 0·027) compared with control 31 (39%)
(Table 1). There was no diﬀerence in the PBMC
production of IL-10, IL-12 andTNF-αbyPBMCs in
vitro in the Blastocystis spp. infected and control
groups (Table 1). Patients with D-IBS infected with
Blastocystis sp. type 1 demonstrated low PBMC pro-
duction of IL-10 in 36 (90%) compared with control
37 (46%) (P<0·001) (Fig. 1). Themean concentration
of IL-10 (14·5±1·6 pgmL−1, P<0·001) was low in
Blastocystis sp. type 1 compared with those with
Blastocystis sp. type 3 (16·7±1·5 pgmL−1) and
controls (16±2·3 pgmL−1) (Table 4), and these
diﬀerences remained signiﬁcant after adjustment
for multiple comparisons, P<0·001 and P<0·001,
respectively (Table 4).
Comparison between Blastocystis spp. types with
PBMC expressed cytokines and histology
In Blastocystis sp. type 1, mucosal lymphocyte and
IEL inﬁltrationwere 15 (37%) (P= 0·039) and 17 (43)
(P= 0·050), respectively compared with control of
16 (20%) and 20 (25%) (Table 3). In Blastocystis sp.
type 1, IL-8 was associated with mild eosinophil
inﬁltration in 18 (72%) (P= 0·024); IL-10 with
lymphocyte in 25 (69%) (P = 0·015), plasma cell
Table 4. Comparison of peripheral cytokines with B. hominis types and control
Mean±S.D.
P value
Over all
B hominis
type 1 vs 3
B hominis
type 1 vs control
B hominis
type 3 vs control
Blood IL-8 BH type1 (n= 40) 12·3±4·5 0·929 NS NS NS
BH type 3 (n= 40) 12·2±3·5
Control (n= 80) 12·5±4
Blood IL-10 BH type1 (n= 40) 14·5±1·6 <0·001* <0·001* <0·001* 0·367
BH type 3 (n= 40) 16·7±1·5
Control (n= 80) 16·0±2·3
Blood IL-12 BH type1 (n= 40) 5·0±1 0·786 NS NS NS
BH type 3 (n= 40) 5·2±1
Control (n= 42) 5·2±1
Blood TNF-α BH type1 (n= 40) 10·4±4·0 0·051 NS 0·054 NS
BH type 3 (n= 40) 9·5±3·2
Control (n= 82) 8·5±4·5
* P value <0·05 was considered as statistically signiﬁcant; NS = not signiﬁcant; S.D. = Std. deviation.
Fig. 2. Comparison of cytokine mRNA expression in colonic mucosa between B. hominis subtypes and control group.
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inﬁltration in 30 (83%) (P= 0·002) and IEL in 23
(64%) (P= 0·026) (Figs 3–5); IL-12 was associated
with goblet cell depletion in 13 (100%) (P<0·001)
and IEL in 9 (69%) (P = 0·038) and TNF-α also with
plasma cell inﬁltration in 12 (100%) (P = 0·019)
(Table 5). In Blastocystis sp. type 3, IL-8 was
associated with goblet cell depletion in 16 (80%)
(P= 0·010) and IEL in 8 (40%) (P= 0·003); IL-10 in
above mean values with mild lymphocyte in 24 (86%)
(P= 0·002) and plasma cell inﬁltration in 28 (100%)
(P<0·001); IL-12 was associated with goblet cell
depletion in 20 (71%) (P = 0·037) and TNF-α was
associated with lymphocyte in 12 (50%) (P= 0·001)
and plasma cell inﬁltration in 8 (33%) (P= 0·013)
(Table 5).
Comparison between Blastocystis spp. types and
cytokine mRNA expression in colonic mucosa
The expression of IL-8 mRNA (pgmL−1) in colonic
mucosa in Blastocystis sp. type 1 (median with
interquartile range) was 3·4 (1·04–7·30), type 3 was
1·2 (0·21–2·14) and for control was 1 (0·27–9·8)
(P= 0·016). The expression of IL-10 mRNA
(pgmL−1) in colonic mucosa in Blastocystis sp.
type 1was 0·78 (0·34–5·7), type 3 was 1 (0·97–0·99)
and for control was 0·27 (0·04–3·6) (P= 0·153). The
expression of IL-12 mRNA (pgmL−1) in colonic
mucosa in Blastocystis sp. type 1 was 1·5 (1·2–5·15),
type 3 was 2 (0·22–7·06) and for control was 1
(2·1–13·8) (P= 0·005). The expression of TNF-α
mRNA (pgmL−1) in colonic mucosa in Blastocystis
sp. type 1 was 0·54 (0·05–1·5), type 3 was 0·87
(0·53–1·8) and for control was 6·7 (2·03–14·7)
(P<0·001). The IL-8mRNA expression was in-
creased in Blastocystis sp. type 1 compared with type
3 (P = 0·001) and control (P= 0·001) (Fig. 2). The
expression of mRNA of IL-10 was low in the control
group and Blastocystis sp. type 3 and type 1 (Fig. 2).
The IL-10 mRNA expression was increased in
Blastocystis sp. type 1 compared with control
(P= 0·016) (Fig. 2). The expression of mRNA of
IL-12 was higher in the control group compared with
Blastocystis sp. type 3 and type 1 (P<0·001 and 0·005,
respectively) (Fig. 2). The expression of mRNA of
TNF-α was higher in the control group compared
with Blastocystis sp. type 3 and type 1 (P =<0·001
and 0·001, respectively) (Fig. 2).
DISCUSSION
Blastocystis spp. is an extracellular luminal organism.
It is able to evade the host immune response by
suppressing iNoS production and cleaving immuno-
globulin (Puthia et al. 2005; Mirza et al. 2011). This
may also compromise these protective responses to
other coinfecting pathogens allowing them to infect
host epithelia and cause disease. There have been
studies investigating the priming of human immune
responses by intestinal protozoa (Djuardi et al. 2010).
The presence of Blastocystis spp. as the predominant
Fig. 3. Colonic glands showing intraepithelial
lymphocytes in the glandular lining epithelium. H&E
×10.
Fig. 5. Colonic glands showing mucin (goblet cell)
depletion. H&E ×20.
Fig. 4. Colonic glands showing intraepithelial
lymphocytes in the glandular lining epithelium H&E
×20.
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Table 5. Comparison between B. hominis types, peripheral blood mononuclear cells cytokines and histological parameters
IL8 IL-10 IL-12 TNF
<12·4 pg
mL−1
512·4 pg
mL−1 P
<15·8 pg
mL−1
<15·8 pg
mL P
<5·2 pg
mL
<5·2 pg
mL−1 P
<9·3 pg
mL−1
59·3 pg
mL P
B. Hominis
TYPE 1
Lymphocyte
Grade Mild 15 (60) 10 (67) 0·673 25 (69) 0 0·015 16 (59) 9 (69) 0·542 9 (75) 16 (57) 0·477
Moderate 10 (40) 5 (33) 11 (31) 4 (100) 11 (41) 4 (31) 3 (25) 12 (43)
Plasma cell
Grade Mild 19 (76) 11 (73) 0·850 30 (83) 0 0·002 19 (70) 11 (85) 0·451 12 (100) 18 (64) 0·019
Moderate 6 (24) 4 (27) 6 (17) 4 (100) 8 (30) 2 (15) 0 (0) 10 (36)
Neutrophil
Grade Absent 18 (72) 8 (53) 0·231 22 (61) 4 (100) 0·278 18 (67) 8 (61) 1 6 (50) 20 (71) 0·193
Mild 7 (28) 7 (47) 14 (39) 0 9 (33) 5 (39) 6 (50) 8 (29)
Eosinophil
Grade Absent 7 (28) 10 (67) 0·024 17 (47) 0 0·123 10 (37) 7 (54) 0·314 7 (58) 10 (36) 0·185
Mild 18 (72) 5 (33) 19 (53) 4 (100) 17 (63) 6 (46) 5 (42) 18 (64)
Goblet cell depletion
Grade Absent 12 (48) 11 (73) 0·117 19 (53) 4 (100) 0·123 23 (85) 0 (0) <0·001 3 (25) 20 (71) 0·013
Mild 13 (52) 4 (27) 17 (47) 0 4 (15) 13 (100) 9 (75) 8 (29)
Intra-epithelial cell
Grade Absent 12 (48) 11 (73) 0·187 23 (64) 0 0·026 19 (70) 4 (31) 0·038 7 (58) 16 (57) 0·944
Mild 13 (52) 4 (27) 13 (36) 4 (100) 8 (30) 9 (69) 5 (42) 12 (43)
B. Hominis
TYPE 3
Lymphocyte
Grade Mild 16 (80) 12 (60) 0·168 4 (33) 24 (86) 0·002 16 (57) 12 (100) 0·007 16 (100) 12 (50) 0·001
Moderate 4 (20) 8 (40) 8 (67) 4 (14) 12 (43) 0 (0) 0 12 (50)
Plasma cell
Grade Mild 16 (80) 16 (80) 0·999 4 (33) 28 (100) <0·001 20 (71) 12 (100) 0·079 16 (100) 16 (67) 0·013
Moderate 4 (20) 4 (20) 8 (67) 0 8 (29) 0 (0) 0 8 (33)
Neutrophil
Grade Absent 12 (60) 12 (60) 0·999 4 (33) 20 (71) 0·037 16 (57) 8 (67) 0·729 12 (75) 12 (50) 0·144
Mild 8 (40) 8 (40) 8 (67) 8 (29) 12 (43) 4 (33) 4 (25) 12 (50)
Eosinophil
Grade Absent 12 (60) 8 (40) 0·206 8 (67) 12 (43) 0·301 16 (57) 4 (33) 0·301 8 (50) 12 (50) 0·999
Mild 8 (40) 12 (60) 4 (33) 16 (57) 12 (33) 8 (67) 8 (50) 12 (50)
Goblet cell depletion
Grade Absent 12 (60) 4 (20) 0·010 4 (33) 12 (43) 0·729 8 (29) 8 (67) 0·037 8 (50) 8 (33) 0·292
Mild 8 (40) 16 (80) 8 (67) 16 (57) 20 (71) 4 (33) 8 (50) 16 (67)
Intra Epithelial cell lymphocyte
Grade Absent 20 (100) 12 (60) 0·003 8 (67) 24 (86) 0·211 24 (86) 8 (67) 0·211 16 (100) 16 (67) 0·013
Mild 0 8 (40) 4 (33) 4 (14) 4 (14) 4 (33) 0 8 (33)
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species in pregnant mothers was shown to dampen
the innate and adaptive responses to puriﬁed protein
derivative (PPD) of mycobacterium tuberculosis
(Djuardi et al. 2010). Earlier studies have shown
that Blastocystis spp. infection can be associated with
impaired intestinal permeability (Mirza et al. 2012)
as well as lower total leucocyte and neutrophil count
(Reiman et al. 2006).
In this study, colonoscopic examination of
D-IBS patients with Blastocystis spp. demonstrated
no pathological changes or only non-speciﬁc inﬂ-
ammation without evidence of invasion with
Blastocystis spp., in keeping with previous studies
(Chen et al. 2005). Also, Blastocystis strain RN94-9
induced neither epithelial injury nor inﬂammatory
cell inﬁltration in rat caecal mucosa (Iguchi et al.
2009). The non-invasive nature of strain RN94-9 was
further conﬁrmed by normal expression levels of
epithelial tight junction proteins. In D-IBS with
Blastocystis spp. infection, PBMCs IL-8 and IL-10
responses were less marked in Blastocystis sp. type 1
compared with control (Table 3). The mean IL-10
was signiﬁcantly lower in Blastocystis sp. type 1
compared with Blastocystis sp. type 3 and control
(Table 4). InBlastocystis sp. type 1, there was colonic
mucosal eosinophil inﬁltration associated with IL-8
compared with Blastocystis sp. type 3 (Table 5) and
lymphocyte inﬁltration and goblet cell depletion
compared with control (Table 3). In contrast, in a
mouse model of Blastocystis spp. infection (Iguchi
et al. 2009) goblet cell hyperplasia was reported.
Moreover, goblet cell hyperplasia has also been
reported in Giardia infections as well (Ponce-
Macotela et al. 2008). It is known that T helper
type 2 cytokines (IL-13 and IL-4) regulate the
development of goblet cell hyperplasia in the gut
during infection and an increased number of goblet
cells plays an important role in host protective
immunity against infection (Khan and Alkhalife,
2005). Goblet cell hyperplasia, increased mucin and
ﬂuid secretion and enhanced intestinal propulsive
activity results in the eviction of noxious agents from
the gut lumen. However, a single administration of
recombinant adenovirus vector expressing IL-12
(Ad5IL-12) in Trichinella spiralis-infected mice
inhibited infection-induced muscle hypercontracti-
lity and goblet cell hyperplasia. This also correlated
with upregulated interferon-γ (IFN-γ) expression
and downregulated IL-13 expression in the muscu-
laris externa layer (Khan et al. 2001). These results
indicate that transfer and overexpression of the IL-12
gene during Th2-based infection shifts the immune
response towards Th1 and abrogates the physiologi-
cal responses to infection, attenuating both muscle
hypercontractility and goblet cell hyperplasia
(Khan et al. 2001). O’Malley et al. (2010) reported
goblet cell hyperplasia in a rat model of anxiety
and depression. The ﬁnding of goblet cell
depletion in both case and control in this study isB
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surprising and may be explained on the basis that
Th2 reaction when replaced by a proinﬂammatory
reaction leads to goblet cell depletion in D-IBS in
humans.
IL-12 plays a key role in induction of Th1 immune
responses by stimulating the production of IFN-γ
and TNF-α from T and natural killer (NK) cells. In
this study, IL 12 was associated with goblet cell
depletion in both cases and control (Table 5). Long
et al. (2001) in an in vitro study reported Blastocystis
sp. type 1 elicited a signiﬁcant increase in proinﬂam-
matory IL-8 in HT-29 and T-84 IEC human colonic
cell lines. This was observable after 24 h exposure to
parasites (Long et al. 2001). However, the PBMCs
culture supernatants harvested after 72 h of incu-
bation did not show signiﬁcant cytokine variation
among Blastocystis spp. types and control (Tables 4
and 5). It has been previously reported that cytokine
changes presented within 6 h (Long et al. 2001) and
normalized after that period. IL-10, having a
regulatory role, is produced by activated lymphocytes
in later phases of the immune response (Schröder
et al. 1987; De Waal Malefyt et al. 1991). The anti-
inﬂammatory cytokine IL-10 inhibits monocytes
production of pro-inﬂammatory cytokines including
TNF-α which subsequently regulates both early
neutrophilic inﬁltration and eosinophil recruitment
(Asseman et al. 1999). Secretion of IL-10 is also
induced by TNF-α linking its production to inﬂ-
ammation (Powrie et al. 1994). In Blastocystis spp.
type 1 and type 3, IL-12 and TNF-α mRNAs
expression were also low compared with in control
(Fig. 2). The low IL-12 and TNF-α in coinfection
with Blastocystis spp. may be attributed to the
immune modifying eﬀect of Blastocystis spp.
Previously, the downregulation of IFN-γ and
TNF-α together with the upregulation of IL-6,
IL-8, as well as NF-κB gene expressions were seen
in the PBMCs stimulated with 1 μgmL−1 of
Blastocystis antigen. This suggested that Blastocystis
antigen stimulated the humoral immune responses in
PBMCs, which may lead to inﬂammatory reactions
and propagation of the cells to combat the infection
(Chandramathi et al. 2010).
IL-10 is important in regulating inﬂammatory
response as it reduces the production of chemotactic
factors, such as IL-8 (Turner et al. 1997; Olivo-Diaz
et al. 2012). Previously in animal models, gene
transcription of type 1 and proinﬂammatory cyto-
kines IFN-γ, IL-12 and TNF-α was signiﬁcantly
upregulated in the caecal mucosa. These results
suggest that Blastocystis infection in rats induces
local host responses to exposed antigens (Iguchi
et al. 2009). In D-IBS with Blastocystis spp., the
IL-8mRNA expression was increased in Blastocystis
sp. type 1 compared with type 3 (P = 0·001) and
control (P = 0·001) (Fig. 2). In keeping with the
previous studies that showed Blastocystis strains N
and II that belong to subtype 1 and WR1 belonging
to subtype 4 stimulated the release of chemokine
IL-8 from a human colonic epithelial cell line in vitro,
possibly mediated by the organism-derived cysteine
protease (Long et al. 2001; Puthia et al. 2005).
Blastocystosis may not be a highly inﬂammatory
disease (at least in the context of these isolates)
as evidenced by low levels of cytokine among
Blastocystis spp. types and control. The severity of
Blastocystosis spp. infection may be mediated by host
factors. Secretion of high levels of enteric anti-
Blastocystis IgA has been found to be a common
factor in all symptomatic, but not asymptomatic,
cases of Blastocystis (Mahmoud and Saleh, 2003).
This would also explain why some individuals can
be carriers of the organism without expressing
symptoms (Markell and Udkow, 1986).
The limitation of this study is that the case-to-
control patient ratio of 1:1 is too small to draw any
ﬁrm conclusion. A case-to-control ratio of 2:1 or 3:1
would have been preferable. The size of the case
group was limited by the number of eligible patients
fulﬁlling the Rome III criteria for D-IBS infected
with Blastocystis sp. subtype 1 or 3 and the resources
required for experiments on this sample size. In
conclusion, in patients with D-IBS and concomitant
Blastocystis sp. type 1 infection, there is a low IL10
response compared with type 3 and D-IBS without
Blastocystis spp. and this may be attributable to an
immune modifying eﬀect of Blastocystis sp. infection
in D-IBS.
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